Searched for
BAYER PHARMA AG
Bayer CropScience Q2 profit rises slightly to Rs 170 croreTotal income rose to Rs 1,356.5 crore against Rs 1,249.1 crore.- Bayer completes merger of Monsanto IndiaThe National Company Law Tribunal (NCLT) last week approved the merger of Monsanto India Ltd with Bayer CropScience.
- NCLT okays merger of Monsanto India with Bayer CropScienceThe National Company Law Tribunal (NCLT) on Friday approved the merger of biotech company Monsanto India Ltd with Bayer CropScience.
- Bayer to complete acquisition of Monsanto on June 7In India, both entities have presence in production and sale of vegetable seeds, cotton seeds as well as in production and sale of non-sele...
- Monsanto India Q3 profit up 47% at Rs 60 croreIts net profit stood at Rs 40.76 crore in the year-ago period, the company said in a regulatory filing.
- Monsanto shares gain over 6% on Bayer open offerOn September 14, Bayer AG announced acquisition of Monsanto for $66 billion to create the world's biggest seed and pesticide firm.
- Monsanto to consider Bayer's revised proposal for acquisitionBayer had raised its all-cash offer to Monsanto shareholders from $ 122 to $ 125/share. It also offered a $ 1.5-billion reverse anti-trust ...
- Bayer challenges IPAB’s compulsory licence order to Natco Pharma on cancer drug Nexavar“We introduce the product after years of research and investment, while companies like Natco merely copy and manufacture the product,” said...
- Pfizer to appeal India decision to revoke cancer drug patentPfizer Ltd, the India unit of US drugmaker Pfizer Inc, will challenge the country's patent office for revoking a patent for its cancer drug...
- Bayer says it will defend its intellectual property rights on cancer drugBayer today said it will continue to defend its IP rights while expressing disappointment at the IPAB decision to reject the firm's plea to...
- Intellectual Property Appellate Board postpones Bayer's compulsory licence appealIPAB has postponed German company Bayer AG's appeal against the grant of a compulsory licence of its patented drug Nexavar to Natco Pharma ...
- Piramal unit and IBA Molecular ink pact for European, US marketsPiramal Imaging said that it has entered into a pact with IBA Molecular for manufacture and distribution of its diagnostic imaging agent.
- Piramal acquires molecular imaging R&D portfolio of BayerPiramal Healthcare today announced its second major acquisition with worldwide rights to the molecular imaging research and development por...
- Bayer AG expects India sales to double by 2015Bayer AG said it expects sales in India to double by 2015 and targets more than 60% increase in revenue from entire Asia during the period
- Zydus Cadila in talks to market Bayer drugsAhmedabad-based drugmaker Zydus Cadila is in talks with Bayer Schering Pharma AG to market the German firm’s products in Indian retail mark...
- SC rejects Bayer’s plea to stay Cipla’s cancer cloneThe Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Baye...
- No interim stay on Cipla’s Nexavar cloneThe Supreme Court turned down a request by German drugmaker Bayer AG to stop Mumbai-based Cipla from launching the low-cost version of Baye...
- Hikal commissions new agro-chemical plant at TalojaHikal Limited, on Monday announced the commissioning of its new multi-purpose agro-chemical plant at Taloja.
- Biocon in talks with Bayer for drug developmentTwo pharma cos may sign pact involving co-development of new biotech drugs & research services.
- Bayer group to sell diagnostics biz to SiemensMultinational healthcare and pharmaceutical major Bayer Group on Friday said it is planning to sell its diagnostics business to Siemens AG,...
Load More
